SyzOnc has opened in Philly's B+labs!

We aim to target matrix-rich tumors by combining advanced computational and biological technologies from Anne Carpenter's lab at Broad and Karin Eisinger's at Penn.

Thrilled to announce Tim Considine as our new CEO 🚀

We are aligned against cancer!